Research News

DriverDetect Software: Enhancing Cancer Mutation Prediction with Machine Learning

Detecting cancer-driving mutations is crucial for understanding cancer and developing treatments. Existing prediction tools vary in accuracy. N2CR member A/Prof Chen Ee Sin co-led the study on DriverDetect, a machine learning algorithm (developed in NUS) that combines outputs from seven tools to better predict driver mutations. Trained on cancer-specific mutation datasets, it outperformed individual tools in validation tests. DriverDetect can integrate new prediction algorithms and be retrained with new data, making it suitable for broad cancer analysis and cross-cancer studies.

Click here to read more.

Share this story:
Facebook
Twitter
LinkedIn

Related Research News

Research News

Understanding RNA Changes and Cancer Development

Led by N2CR member A/Prof Polly Chen, this research highlights the crucial role of ‘death associated protein 3’ (DAP3) in …

Read More →
Achievements

New CAR T-Cell Therapy Offers Hope for Relapsed or Refractory T-cell Leukaemia

Relapsed/refractory T-cell acute lymphoblastic leukemia (T-ALL) is challenging to treat. Outcome for such patients is dismal. A recent experimental treatment …

Read More →
Research News

New Hope for Gastric Cancer Patients with Peritoneal Metastasis

A breakthrough study, co-led by N2CR member A/Prof Raghav Sundar and includes Prof Jimmy So, A/Prof Yvonne Tay and Dr …

Read More →